PRE Prenetics Global Limited

NASDAQ
$19.75

Prenetics Global Limited (PRE) is confirmed to report earnings on August 18, 2026, before the market open. The consensus earnings estimate is a loss of $0.32 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -2.2% since its last earnings release on June 10, 2026.

Prenetics Global Limited Missed Consensus Estimates
Wednesday, June 10, 2026 · 8:30 AM ET
Earnings Date
2nd Quarter, Jun 2026
Aug 18
Tuesday · 8:30 AM ET
Earnings Whisper
-
vs ($0.32)
Rev est $48.77M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $19.65

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Prenetics Global Limited

Prenetics is a major global diagnostics and genetic testing company with the mission to bring health closer to millions of people globally and decentralize healthcare by making the three pillars — Prevention, Diagnostics and Personalized Care — comprehensive and accessible to anyone, at anytime and anywhere.

Sector

Healthcare

Industry

Biotechnology